What endometriosis is

Endometriosis is a condition involving tissue similar to the uterine lining outside the uterus. It can be associated with pain and difficulty becoming pregnant, but its presentation varies. Understanding it requires keeping several questions separate: what symptoms are happening, what an examination or image shows, what remains uncertain, and what a care plan is trying to improve. A symptom history, an imaging report, and a surgical finding each contribute different information. None is a complete description of a person's experience. ^[1][2]

The definition describes tissue and location

The word endometriosis refers to tissue resembling endometrium, the lining of the uterus, occurring outside the uterus. The definition identifies a disease process; it does not specify one symptom pattern, one appearance on imaging, or one inevitable course. The major European guideline describes a range of presentations and considers pain and infertility as separate concerns. That distinction matters when reading an account that treats all endometriosis as one uniform experience. ^[2]

“Endometrial-like” is a description of resemblance. It should not be read as a complete explanation of where the tissue came from or why a particular person developed the condition. The guideline organizes care around clinical questions rather than requiring one universal origin story. It also addresses situations beyond the most commonly studied reproductive-age population, including adolescence and disease after menopause. These groups are part of the guideline's scope, although scope alone does not establish that the evidence is equally strong for every group. ^[2]

A definition is therefore a starting point for understanding a report. It cannot, by itself, answer whether a finding explains a specific symptom, whether another condition is present, or which intervention would meet a person's goals. Keeping the definition separate from those later judgments avoids turning a disease label into a prediction about an individual. The guideline's range of diagnostic and management questions illustrates how much remains to be considered after the name of the condition is known. ^[2]

Symptoms and visible findings answer different questions

Clinical evaluation asks about symptoms, their pattern, and the circumstances in which they occur. Imaging and surgery ask different questions about structures and findings. The American College of Obstetricians and Gynecologists' diagnostic guideline explicitly covers clinical, imaging, and surgical evaluation. These are related sources of information, rather than interchangeable names for the same test. A symptom description belongs in the assessment even when the subsequent report uses anatomical language instead of describing daily life. ^[3]

For example, a statement about a finding on a scan is a statement about that examination. It is not a direct measurement of the number of difficult days, the disruption to an activity, or the meaning of a symptom to the person experiencing it. Conversely, a description of severe disruption does not identify a particular anatomical site. This separation follows from the different roles of clinical and imaging evaluation in the diagnostic guideline; it is a way of reading their outputs carefully, rather than a rule for diagnosing a condition. ^[3]

The same distinction helps with apparent disagreement between records. A clinical note may preserve a symptom concern while an imaging report describes what was visible. The two records need not be making opposite claims. A useful interpretation asks what each record actually evaluated before deciding that one has disproved the other. The diagnostic guideline includes recommendations with different strengths and evidence quality, as well as good-practice statements where formal evidence is inadequate. That structure itself cautions against treating every step in evaluation as equally certain. The recommendation type and its evidence grade remain relevant context. ^[3]

Ultrasound is an examination with a purpose

Ultrasound is commonly used in the assessment of pelvic pain and infertility. A Society of Radiologists in Ultrasound consensus statement explains that routine transvaginal examinations may fail to recognize endometriosis beyond an ovarian endometrioma. Its panel proposed additional observations, including assessment of the posterior compartment, relative organ positions, and the uterine sliding sign. The central lesson is about the examination's purpose and technique, rather than a claim that an ordinary scan always provides a complete endometriosis assessment. ^[4]

The statement was produced through literature review and expert consensus. It sets out a reporting approach intended to improve recognition and communication. That is different from a trial showing that every service has adopted the approach or that every patient will receive an earlier diagnosis. Recommendations describe a proposed standard of practice; implementation and results still require evidence. A report can therefore be read with attention to which structures and observations it actually documents. ^[4]

This distinction is especially relevant to the phrase “normal ultrasound.” Without the examination details, the phrase does not say whether an endometriosis-focused protocol was used or whether particular signs were assessed. The consensus document gives a concrete reason to preserve that context. It supports asking what was evaluated, while avoiding a promise that adding one maneuver or repeating one scan will resolve an individual case. ^[4]

Different forms have different visibility

A prospective diagnostic study examined 125 people aged 18–50 with suspected endometriosis who underwent ultrasound followed by laparoscopy. The ultrasound followed the International Deep Endometriosis Analysis approach, and the investigators compared its findings with surgical and histopathological findings. In that selected group, performance was substantially stronger for ovarian and deep endometriosis than for superficial disease. The study therefore provides evidence about several different detection problems, rather than one accuracy figure for all endometriosis. ^[5]

The distinction between sensitivity and specificity helps explain this result. Sensitivity concerns how often a test detects the target finding among people who have it according to the study's reference standard. Specificity concerns how often the test is negative among those who do not have that finding. A study can report high specificity while still missing a substantial proportion of one form of disease. In this study, the superficial-disease results illustrate why a negative finding needs to be interpreted in relation to what was being sought. ^[5]

The participants were already undergoing a pathway that included surgery. They were not a random sample of everyone with period pain or everyone having a routine pelvic ultrasound. That limits how directly the results can be transferred to other settings. The findings support careful communication about ovarian, deep, and superficial disease; they do not supply a personal probability for someone reading a scan report outside the study. ^[5]

MRI contributes mapping and communication

A European Society of Urogenital Radiology consensus addresses when MRI can contribute to endometriosis assessment and how findings should be reported. Its scope includes situations in which transvaginal ultrasound is inconclusive or negative despite symptoms, assessment before an intervention, and persistent symptoms after surgical treatment. These are panel recommendations about the role of MRI, not an instruction that every person with pelvic pain needs that test. ^[6]

The consensus places particular emphasis on a structured report organized by anatomical compartments. Mapping is useful because the location and extent of visible findings can be relevant to planning and communication. A structured description also makes it easier to see which observations were made instead of reducing an examination to a single positive or negative label. The panel considered communication with both surgeons and patients important, and discussed optional drawings as one way to support that conversation. ^[6]

An MRI report still needs to be read as an imaging report. A map of visible findings does not measure all symptoms or establish how every treatment will work. The consensus developed recommendations through surveys of imaging experts; it did not follow a universal patient population through every possible outcome. That limitation matters whenever the word “recommended” is mistaken for a guarantee. The document supports clearer examination and reporting practices while leaving individual clinical decisions to the broader assessment. ^[6]

Surgery is one source of diagnostic information

The diagnostic guideline from the American College of Obstetricians and Gynecologists includes surgical evaluation alongside clinical assessment and imaging. The European guideline similarly describes a diagnostic process that reconsiders the historical treatment of laparoscopy and histology as the sole diagnostic gold standard. Together, these sources support a more careful account than “a diagnosis always requires surgery.” They also do not establish the opposite rule that surgery never has a diagnostic role. ^[2][3]

An operation, a visual observation, and a pathology result are distinct parts of a record. The prospective ultrasound study, for instance, compared imaging with both laparoscopic and histopathological findings. Calling all of these simply “the test” would obscure what was actually observed and which reference was used. When research reports accuracy, the reference standard is part of the result, because it defines the comparison against which the index test was judged. ^[5]

The reason to preserve these distinctions is practical: a conclusion should remain attached to the evidence that produced it. A clinical impression, an imaging interpretation, and a pathology description may carry different kinds of uncertainty. A broad educational explanation cannot decide whether an operation is appropriate for an individual. The guidelines provide frameworks for assessment, while their differing evidence grades and acknowledged gaps make clear that a pathway is more complex than a mandatory sequence of tests. ^[2][3]

Pelvic pain can require a wider assessment

A practice bulletin on chronic pelvic pain addresses pain that is not fully explained by identifiable gynecologic, urinary, or gastrointestinal pathology. It describes the complexity of care and the role of multidisciplinary input. Its scope is important: persistent pain can remain a care question even when a search for one structural explanation has not supplied a complete answer. That does not establish a psychological cause or make the symptom less real. It identifies a limit in the explanatory reach of a particular finding. ^[8]

The bulletin also notes that some recommendations draw on evidence from other chronic pain conditions when direct pelvic-pain evidence is limited. Extrapolation can inform practice, but it is not the same as direct evidence from the exact population and intervention under discussion. An honest explanation keeps that boundary visible. It avoids presenting all care recommendations as though they came from large, definitive trials conducted specifically in people with the same pelvic-pain presentation. ^[8]

This wider view does not require choosing between endometriosis and pain care as competing accounts. The bulletin's focus is the portion of pain not fully explained by identified pathology, while condition-specific guidance addresses potential gynecologic causes. Those scopes can sit beside one another. An anatomical question and a functional question can both remain open, with different professionals contributing different forms of expertise. The research framework supports coordinated assessment rather than a single finding being made responsible for every concern. ^[8]

Genetics is research about groups

A large genome-wide association meta-analysis included more than 60,000 endometriosis cases and more than 700,000 controls of European and East Asian descent. It identified multiple associated genetic regions and reported shared genetic patterns with several pain and inflammatory conditions. Those results add to biological research; they do not amount to an individual diagnostic test or show that one genetic variant determines a person's symptoms. ^[7]

The study also illustrates why population and outcome matter. The strongest associations were seen for some disease categories, and the authors called for targeted investigation of shared mechanisms. A group-level association can generate useful hypotheses without resolving which mechanism is active in an individual. The ancestry of the included populations is another boundary on interpretation. Reporting who was studied and what was measured is more informative than turning a large sample size into a claim that the findings explain every case. ^[7]

Adenomyosis is related in discussion, separate in anatomy

Adenomyosis concerns endometrial glands and supporting tissue within the muscular wall of the uterus. An integrated diagnostic review describes it as a benign uterine disorder that may be associated with bleeding, pelvic pain, or fertility concerns, while some people have no symptoms. It also notes coexistence with endometriosis and fibroids. These features explain why the conditions are often discussed together without making them synonyms. ^[10]

The Canadian adenomyosis guideline treats heavy menstrual bleeding, pain, and infertility as separate concerns when describing management options. That structure reinforces a distinction useful in reading any pelvic-health record: naming a condition does not automatically identify the person's principal goal. A discussion centered on bleeding may require different outcome measures from one centered on pain or fertility. An article about endometriosis cannot substitute for a separate assessment of a finding in the uterine muscle. ^[9]

Overlapping symptoms are therefore an invitation to keep the anatomy and the clinical questions clear. A symptom does not label its own source, and one documented condition does not establish that every other possibility has been assessed. The adenomyosis review describes diagnostic criteria as still lacking universal agreement. That uncertainty belongs with the evidence, especially when comparing records that used different imaging criteria or were produced in different settings. ^[10]

Treatment evidence needs a named outcome

The European endometriosis guideline considers pain treatment, infertility management, recurrence, and other clinical situations in separate sections. It discusses analgesic, medical, surgical, and non-pharmacological approaches, while acknowledging areas where available evidence does not establish a most appropriate option. A list of possible interventions is therefore not a ranking that applies to everyone. It is a set of approaches evaluated against different questions and evidence bases. ^[2]

Pain relief and an infertility outcome are not interchangeable measures of success. Neither is identical to avoiding another intervention or improving everyday function. When a source says a treatment helped, the next interpretive step is to identify what “helped” meant in that study or recommendation. The guideline's separate treatment questions provide a reason to preserve these distinctions rather than converting improvement in one endpoint into a promise about the whole condition. ^[2]

The same care applies to evidence gaps. A guideline may include a recommendation based partly on consensus because the available research is limited. That does not mean the recommendation was casually made, and it does not transform consensus into a direct trial result. The American diagnostic guideline explicitly distinguishes graded recommendations from good-practice points. Naming the type of support allows patients and care teams to discuss uncertainty without treating uncertainty as failure. ^[3]

Reading a record without losing its limits

A useful way to organize the information in these sources is to separate the symptom account, the examination or imaging question, the observed finding, and the interpretation. This is an explanatory framework, not a validated scoring system. It reflects the diagnostic guideline's separation of clinical, imaging, and surgical evaluation and the imaging consensus documents' emphasis on clear reporting. Each piece can retain its meaning without being stretched into an answer to every other question. ^[3][4][6]

Consider an illustrative report that says no endometrioma was identified. That statement concerns an ovarian finding. It does not, simply through its wording, say that a focused assessment for every deep or superficial site was completed. The diagnostic study showing different performance across forms of endometriosis explains why those claims should remain separate. The example is about reading the scope of a sentence; it is not an interpretation of a real person's scan. ^[5]

Likewise, a plan that records a question for a later assessment is different from a confirmed diagnosis. Keeping an unresolved question visible preserves the distinction between current evidence and a future decision. The diagnostic guidelines and reporting consensus statements support a staged account of assessment, with the type and limits of available evidence explicit. A source-linked record can describe what is known while leaving room for a clinician and patient to decide what further information would matter. ^[3][6]

What a detection percentage actually counts

The prospective ultrasound study reported sensitivity around 95% for ovarian endometriomas and a range from 84.3% to 100% across the deep sites it assessed. Superficial-disease sensitivity was much lower, ranging from 4.0% to 43.5%. The ranges belong to different findings within one research setting; they are not a single scale of how seriously symptoms should be taken. Reporting the target condition alongside the percentage is essential to preserving what those numbers mean. ^[5]

For illustration, sensitivity concerns the group in whom the reference standard identified the target finding. It is not the percentage of all people receiving a scan who will obtain a diagnosis. Nor is specificity the same as certainty that a particular positive report is correct. The study calculated several measures, including predictive values, precisely because these measures answer different questions. Removing the denominator and the comparison standard would make a seemingly precise number less informative. ^[5]

The researchers used a specified ultrasound approach before surgery and defined the disease categories being assessed. Those details are part of the evidence, alongside the headline percentages. A different protocol, population, or interpretation setting cannot simply inherit the study's estimates. The useful message is narrower and more concrete: the same examination can be better at detecting one type of finding than another, so the description of what was sought belongs beside the result. ^[5]

What this does not tell you

This explanation cannot determine whether any individual has endometriosis, whether a particular finding causes a symptom, or whether a specific test or treatment is appropriate. The cited guidelines address groups and clinical questions; the imaging study examined a selected surgical population. Neither kind of source supplies a diagnosis from a symptom list or a personal forecast from a general accuracy estimate. ^[2][3][5]

It also does not make normal imaging equivalent to the absence of every possible cause of pain. The distinction between superficial, ovarian, and deep disease, together with the broader scope of chronic pelvic-pain assessment, prevents that conclusion. At the same time, limits of detection do not prove that endometriosis is present. They define uncertainty. Clear communication can hold both the reported experience and the limits of an investigation in view without promising a diagnosis, a particular response, or an outcome. ^[5][8]